Cargando…

Ataxia-telangiectasia: A new remitting form with a peculiar transcriptome signature

OBJECTIVE: Ataxia-telangiectasia (AT) is a rare, severe, and ineluctably progressive multisystemic neurodegenerative disease. Variant AT phenotypes have been described in patients with mild- and late-onset neurologic deterioration and atypical features (dystonia and myoclonus). We report on the clin...

Descripción completa

Detalles Bibliográficos
Autores principales:	Leuzzi, Vincenzo, D'Agnano, Daniela, Menotta, Michele, Caputi, Caterina, Chessa, Luciana, Magnani, Mauro
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer 2018
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5873729/ https://www.ncbi.nlm.nih.gov/pubmed/29600275 http://dx.doi.org/10.1212/NXG.0000000000000228

Ejemplares similares

Proteomics and transcriptomics analyses of ataxia telangiectasia cells treated with Dexamethasone
por: Menotta, Michele, et al.
Publicado: (2018)

Positive effect of erythrocyte-delivered dexamethasone in ataxia-telangiectasia
por: Leuzzi, Vincenzo, et al.
Publicado: (2015)

ATM splicing variants as biomarkers for low dose dexamethasone treatment of A-T
por: Menotta, Michele, et al.
Publicado: (2017)

New human ATM variants are able to regain ATM functions in ataxia telangiectasia disease
por: Ricci, Anastasia, et al.
Publicado: (2022)

Activation of NRF2 by dexamethasone in ataxia telangiectasia cells involves KEAP1 inhibition but not the inhibition of p38
por: Biagiotti, Sara, et al.
Publicado: (2019)

Dexamethasone induces p21(cip1/waf1) expression via FoxO3a independently of the Lamin A/C‐HDAC2 interaction in Ataxia Telangiectasia
por: Ricci, Anastasia, et al.
Publicado: (2023)

Intra-Erythrocyte Infusion of Dexamethasone Reduces Neurological Symptoms in Ataxia Teleangiectasia Patients: Results of a Phase 2 Trial
por: Chessa, Luciana, et al.
Publicado: (2014)

Cutaneous granulomatosis and combined immunodeficiency revealing Ataxia-Telangiectasia: a case report
por: Folgori, Laura, et al.
Publicado: (2010)

Functional Classification of the ATM Variant c.7157C>A and In Vitro Effects of Dexamethasone
por: Biagiotti, Sara, et al.
Publicado: (2021)

Myoclonus in Ataxia–Telangiectasia
por: Termsarasab, Pichet, et al.
Publicado: (2015)

Growth in ataxia telangiectasia
por: Natale, Valerie A. I., et al.
Publicado: (2021)

Multi-drugs resistant acne rosacea in a child affected by Ataxia-Telangiectasia: successful treatment with Isotretinoin
por: Cantarutti, Nicoletta, et al.
Publicado: (2015)

DNA methylation and gene expression signatures are associated with ataxia-telangiectasia phenotype
por: McGrath-Morrow, Sharon A., et al.
Publicado: (2020)

Ataxia telangiectasia: Family management
por: Seshachalam, Arun, et al.
Publicado: (2010)

Ataxia-telangiectasia: future prospects
por: Chaudhary, Mohammed Wajid, et al.
Publicado: (2014)

Ataxia telangiectasia: a review
por: Rothblum-Oviatt, Cynthia, et al.
Publicado: (2016)

Correction to: Growth in ataxia telangiectasia
por: Natale, Valerie A. I., et al.
Publicado: (2021)

Ataxia-telangiectasia: immunologic profile and clinical outcome
por: De Lima Honório Dumas, Clarissa, et al.
Publicado: (2015)

DHPLC Screening of ATM Gene in Italian Patients Affected by Ataxia-Telangiectasia: Fourteen Novel ATM Mutations
por: Magliozzi, Monia, et al.
Publicado: (2006)

Linear growth and endocrine function in children with ataxia telangiectasia
por: Ehlayel, Mohammad, et al.
Publicado: (2014)

Bladder Wall Telangiectasia in a Patient with Ataxia-Telangiectasia and How to Manage?
por: Aygün, Fatma Deniz, et al.
Publicado: (2015)

Experimental Antioxidant Therapy in Ataxia Telangiectasia
por: Reliene, Ramune, et al.
Publicado: (2008)

Treatment of Granulomas in Patients With Ataxia Telangiectasia
por: Woelke, Sandra, et al.
Publicado: (2018)

Dysarthria in children and adults with ataxia telangiectasia
por: Veenhuis, Stefanie J G, et al.
Publicado: (2021)

Ataxia Telangiectasia Presenting as Cervical Dystonia
por: LNU, Priyal, et al.
Publicado: (2022)

ATM protein and p53-serine 15 phosphorylation in ataxia-telangiectasia (AT) patients and at heterozygotes
por: Delia, D, et al.
Publicado: (2000)

Nicotinamide Riboside Improves Ataxia Scores and Immunoglobulin Levels in Ataxia Telangiectasia
por: Veenhuis, Stefanie J.G., et al.
Publicado: (2021)

JIA-like in a boy with Ataxia-telangiectasia
por: Furtado, Filipa, et al.
Publicado: (2014)

Nonalcoholic Steatohepatitis in a Patient with Ataxia-Telangiectasia
por: Caballero, Trinidad, et al.
Publicado: (2014)

Disorders of Upper Limb Movements in Ataxia-Telangiectasia
por: Shaikh, Aasef G., et al.
Publicado: (2013)

Retroperitoneal extramedullary hematopoietic pseudotumor in ataxia–telangiectasia
por: Judge, Sean James, et al.
Publicado: (2018)

Progressive Liver Disease in Patients With Ataxia Telangiectasia
por: Donath, Helena, et al.
Publicado: (2019)

Metabolic Stress and Mitochondrial Dysfunction in Ataxia-Telangiectasia
por: Subramanian, Goutham Narayanan, et al.
Publicado: (2022)

Multidisciplinary Management of Ataxia Telangiectasia: Current Perspectives
por: McGrath-Morrow, Sharon A, et al.
Publicado: (2021)

The Role of Respiratory Viruses in Children with Ataxia-Telangiectasia
por: Méndez-Echevarría, Ana, et al.
Publicado: (2021)

Imaging in children with ataxia-telangiectasia—The radiologist’s approach
por: Jończyk-Potoczna, Katarzyna, et al.
Publicado: (2022)

Ataxia-Telangiectasia Mutated Loss of Heterozygosity in Melanoma
por: Pastorino, Lorenza, et al.
Publicado: (2022)

Ataxia-Telangiectasia Mutated Is Involved in Autolysosome Formation
por: Hwang, Mihwa, et al.
Publicado: (2023)

Episodic ataxia and severe infantile phenotype in spinocerebellar ataxia type 14: expansion of the phenotype and novel mutations
por: De Michele, Giovanna, et al.
Publicado: (2021)

Progressive Depletion of B and T Lymphocytes in Patients with Ataxia Telangiectasia: Results of the Italian Primary Immunodeficiency Network
por: Cirillo, Emilia, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_frinfjh719kth43ep7j32u3d57